U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6402164021Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWithdrawnNo Results AvailableMucositis|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell CarcinDrug: entolimod|Radiation: intensity-modulated radiation therapy|Drug: cisplatin|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01728480
6402264022The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetesCompletedNo Results AvailableDiabetesDrug: RVX000222|Drug: Placebo, RVX000222https://ClinicalTrials.gov/show/NCT01728467
6402364023The Evaluation of Safety and Efficacy of Proellex in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic EndometriosisRecruitingNo Results AvailableEndometriosisDrug: Placebo|Drug: Proellex 6 mg|Drug: Proellex 12 mghttps://ClinicalTrials.gov/show/NCT01728454
6402464024Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral ArteryCompletedNo Results AvailablePeripheral Artery DiseaseDevice: Paclitaxel Eluting Stent|Device: Paclitaxel Eluting Balloonhttps://ClinicalTrials.gov/show/NCT01728441
6402564025A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese PatientsCompletedNo Results AvailableHemifacial Spasmhttps://ClinicalTrials.gov/show/NCT01728428
6402664026Effects of High-intensity Interval Training in Patients in HemodialysisRecruitingNo Results AvailableChronic Renal DiseaseOther: exercisehttps://ClinicalTrials.gov/show/NCT01728415
6402764027Pathogenesis of Hematologic MalignanciesEnrolling by invitationNo Results AvailableAcute Leukemia|Lymphoproliferative Disorders|Myeloproliferative Disorders|Myelodysplastic SyndromesProcedure: blood draw, bone marrow procedure, or tissue biopsyhttps://ClinicalTrials.gov/show/NCT01728402
6402864028Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies.RecruitingNo Results AvailableLeukemia|LymphomaProcedure: Intrabone transplantationhttps://ClinicalTrials.gov/show/NCT01728389
6402964029Comparative Evaluation of the Safety & Efficacy of Daptomycin Versus SOC in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)RecruitingNo Results AvailableBacteremiaDrug: Daptomycin|Drug: Comparator (Vancomycin, Semi-synthetic penicillin, First-generation cephalosporins, Clindamycin)https://ClinicalTrials.gov/show/NCT01728376
6403064030Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)CompletedNo Results AvailableSystemic InfectionDrug: Antibiotichttps://ClinicalTrials.gov/show/NCT01728363
6403164031Improving Well-Being After TBI Through Structured Volunteer ActivityRecruitingNo Results AvailableTraumatic Brain InjuryBehavioral: HOPE - Helping Others through Purpose and Engagementhttps://ClinicalTrials.gov/show/NCT01728350
6403264032Phase Iv Study On Muscle Activity Of Two Commercial Preparations Of BotulinumCompletedHas ResultsSun-induced WrinklesDrug: Dysport|Drug: Xeominhttps://ClinicalTrials.gov/show/NCT01728337
6403364033Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2CompletedNo Results AvailableHepatitis C, ChronicDrug: BI 207127-placebo: 8-week treatment|Drug: Ribavirin: 24-week treatment|Drug: BI 207127: 24-week treatment|Drug: Faldaprevir: 24-week treatment|Drug: Faldaprevir: 24-week treatment|Drug: Ribavirin-placebo: 8-week treatment|Drug: BI 207127: 24-week treatment|Drug: Faldaprevir-placebo: 8-week treatment|Drug: Faldaprevir: 16-week treatment|Drug: Ribavirin: 16-week treatment|Drug: RBV: 24-week treatment|Drug: BI 207127: 16-week treatmenthttps://ClinicalTrials.gov/show/NCT01728324
6403464034Open Label Study of BAY1082439 in Patients With Advanced CancerRecruitingNo Results AvailableNeoplasmsDrug: BAY1082439https://ClinicalTrials.gov/show/NCT01728311
6403564035A Dose Response Evaluation of SLITone Ultra HDM Mix ImmunotherapyCompletedNo Results AvailableAllergic RhinitisBiological: SLITone ULTRA HDM immunotherapyhttps://ClinicalTrials.gov/show/NCT01728298
6403664036Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen RhinoconjunctivitisCompletedNo Results AvailableAllergic Rhinitis|Grass AllergyDevice: Electronic compliance device (Memozax®)https://ClinicalTrials.gov/show/NCT01728285
6403764037Influence of CPB and Mini CPB to the Absorption of the MetoprololRecruitingNo Results AvailableDrug AbsorptionDrug: blood concentration of metoprololhttps://ClinicalTrials.gov/show/NCT01728272
6403864038First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDDActive, not recruitingNo Results AvailableLight Chain Deposition Disease|Primary Systemic AmyloidosisDrug: pomalidomide|Drug: bortezomib|Drug: dexamethasonehttps://ClinicalTrials.gov/show/NCT01728259
6403964039An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic OsteoarthritisCompletedHas ResultsOsteoarthritisDrug: Tramadol/Paracetamol (APAP)|Drug: Non-Tramadol/APAPhttps://ClinicalTrials.gov/show/NCT01728246
6404064040Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the PenisNot yet recruitingNo Results AvailablePenile Neoplasms|Carcinoma, Squamous CellDrug: Dacomitinibhttps://ClinicalTrials.gov/show/NCT01728233
6404164041Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPDCompletedNo Results AvailablePulmonary Hypertension|Chronic Obstructive Pulmonary DiseaseDrug: Inhaled NO|Other: Placebohttps://ClinicalTrials.gov/show/NCT01728220
6404264042Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLLRecruitingNo Results AvailableNon-hodgkin's Lymphoma|Follicular Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Chronic Lymphocytic Leukemia|Small Lymphocytic LymphomaDrug: IMMU-114https://ClinicalTrials.gov/show/NCT01728207
6404364043Emotional and Cognitive Control in Late-Onset DepressionRecruitingNo Results AvailableDepressionDrug: Escitalopramhttps://ClinicalTrials.gov/show/NCT01728194
6404464044A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic EvaluationWithdrawnNo Results AvailableNon-small Cell Lung Cancer|Stage IV Disease|EGFR Unknown or Wild-typeDrug: Tivozanib|Drug: Erlotinib|Other: Standard of Care treatmenthttps://ClinicalTrials.gov/show/NCT01728181
6404564045Prevalence of Food Allergies to Proteins From Different LegumesCompletedNo Results AvailableFood Allergyhttps://ClinicalTrials.gov/show/NCT01728168
6404664046European Low and Intermediate Risk Neuroblastoma ProtocolRecruitingNo Results AvailableLOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSESDrug: chemotherapyhttps://ClinicalTrials.gov/show/NCT01728155
6404764047Comparison of the DANA to the ANAM in the Evaluation of Cognitive Changes After ConcussionRecruitingNo Results AvailableTraumatic Brain Injury|Brain ConcussionDevice: DANA Brief|Other: ANAMhttps://ClinicalTrials.gov/show/NCT01728142
6404864048DANA Compared to MACE in Evaluation of Suspected Acute ConcussionRecruitingNo Results AvailableBrain Concussion|Traumatic Brain InjuryDevice: DANA Rapid|Other: MACEhttps://ClinicalTrials.gov/show/NCT01728129
6404964049Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are ObeseTerminatedNo Results AvailableType 2 Diabetes in Obese SubjectsDevice: EndoBarrier|Procedure: Sham Procedurehttps://ClinicalTrials.gov/show/NCT01728116
6405064050Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) AssaysActive, not recruitingNo Results AvailableChlamydia Infections|Gonorrhea|Trichomonas InfectionsDevice: APTIMA® Trichomonas vaginalis & APTIMA® COMBO 2® Assayshttps://ClinicalTrials.gov/show/NCT01728103

* Görseller ve İçerik tekif hakkına sahip olabilir